Advertisement
Screener

IRADIMED CORPORATION (IRMD) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

IRADIMED CORPORATION Operating Cash Flow

IRADIMED CORPORATION (IRMD) reported Operating Cash Flow of $14.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-31

  • IRADIMED CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $5.94M, a 23.33% decline year-over-year.
  • IRADIMED CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $8.29M, a 93.15% increase year-over-year.
  • IRADIMED CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $5.92M, a 1.07% decline year-over-year.
  • IRADIMED CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $6.99M, a 23.37% decline year-over-year.
  • IRADIMED CORPORATION net cash provided by (used in) operating activities for fiscal 2025 was $24.95M, a 2.64% decline from fiscal 2024.
  • IRADIMED CORPORATION net cash provided by (used in) operating activities for fiscal 2024 was $25.62M, a 90.30% increase from fiscal 2023.
  • IRADIMED CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was $13.47M, a 34.08% increase from fiscal 2022.
  • IRADIMED CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was $10.04M, a 10.80% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30$5.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$14.23M
10-Q · filed 2026-07-31
$20.15M
derived: sum of 3 quarters · filed 2026-07-31
$27.14M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$8.29M
10-Q · filed 2026-05-01
$14.21M
derived: sum of 2 quarters · filed 2026-05-01
$21.20M
derived: sum of 3 quarters · filed 2026-05-01
$28.95M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$5.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$12.91M
derived: sum of 2 quarters · filed 2026-03-06
$20.66M
derived: sum of 3 quarters · filed 2026-07-31
$24.95M
10-K · filed 2026-03-06
2025-09-30$6.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03
$14.73M
derived: sum of 2 quarters · filed 2026-07-31
$19.02M
10-Q · filed 2025-11-03
$25.01M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30$7.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$12.04M
10-Q · filed 2026-07-31
$12.04M
10-Q · filed 2025-08-01
$18.03M
derived: sum of 3 quarters · filed 2026-07-31
$27.14M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$4.29M
10-Q · filed 2026-05-01
$4.29M
10-Q · filed 2025-05-05
$10.28M
derived: sum of 2 quarters · filed 2026-05-01
$19.39M
derived: sum of 3 quarters · filed 2026-05-01
$26.03M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$5.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$15.10M
derived: sum of 2 quarters · filed 2026-03-06
$21.74M
derived: sum of 3 quarters · filed 2026-03-06
$25.62M
10-K · filed 2026-03-06
$25.62M
10-K · filed 2025-03-06
2024-09-30$9.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03
$15.75M
derived: sum of 2 quarters · filed 2025-11-03
$19.64M
10-Q · filed 2025-11-03
$23.55M
derived: sum of 4 quarters · filed 2025-11-03
2024-06-30$6.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01
$10.52M
10-Q · filed 2025-08-01
$14.43M
derived: sum of 3 quarters · filed 2025-09-03
$15.83M
derived: sum of 4 quarters · filed 2025-09-03
2024-03-31$3.88M
10-Q · filed 2025-05-05
$3.88M
10-Q · filed 2024-05-02
$7.80M
derived: sum of 2 quarters · filed 2025-09-03
$9.19M
derived: sum of 3 quarters · filed 2025-09-03
$12.70M
derived: sum of 4 quarters · filed 2025-09-03
2023-12-31$3.91M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03
$5.31M
derived: sum of 2 quarters · filed 2025-09-03
$8.82M
derived: sum of 3 quarters · filed 2025-09-03
$13.47M
10-K/A · filed 2025-09-03
2023-09-30$1.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$4.91M
derived: sum of 2 quarters · filed 2024-10-31
$9.55M
10-Q · filed 2024-10-31
$12.59M
derived: sum of 4 quarters · filed 2024-10-31
2023-06-30$3.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
$8.16M
10-Q · filed 2024-08-01
$11.20M
derived: sum of 3 quarters · filed 2024-08-01
$15.14M
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31$4.65M
10-Q · filed 2024-05-02
$7.68M
derived: sum of 2 quarters · filed 2024-05-02
$11.62M
derived: sum of 3 quarters · filed 2024-05-02
$13.26M
derived: sum of 4 quarters · filed 2024-05-02
2022-12-31$3.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
$6.98M
derived: sum of 2 quarters · filed 2024-03-01
$8.62M
derived: sum of 3 quarters · filed 2024-03-01
$10.04M
10-K · filed 2024-03-01
2022-09-30$3.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$5.58M
derived: sum of 2 quarters · filed 2023-11-03
$7.00M
10-Q · filed 2023-11-03
$10.37M
derived: sum of 4 quarters · filed 2023-11-03
2022-06-30$1.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$3.07M
10-Q · filed 2023-08-03
$6.43M
derived: sum of 3 quarters · filed 2023-08-03
$9.81M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31$1.43M
10-Q · filed 2023-05-04
$4.79M
derived: sum of 2 quarters · filed 2023-05-04
$8.17M
derived: sum of 3 quarters · filed 2023-05-04
$11.74M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$3.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$6.74M
derived: sum of 2 quarters · filed 2023-03-02
$10.32M
derived: sum of 3 quarters · filed 2023-03-02
$11.26M
10-K · filed 2023-03-02
2021-09-30$3.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$6.95M
derived: sum of 2 quarters · filed 2022-11-03
$7.89M
10-Q · filed 2022-11-03
$10.39M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$3.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$4.51M
10-Q · filed 2022-08-05
$7.01M
derived: sum of 3 quarters · filed 2022-08-05
$8.34M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$943.08K
10-Q · filed 2022-05-06
$3.44M
derived: sum of 2 quarters · filed 2022-05-06
$4.77M
derived: sum of 3 quarters · filed 2022-05-06
$5.56M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$3.83M
derived: sum of 2 quarters · filed 2022-03-04
$4.62M
derived: sum of 3 quarters · filed 2022-03-04
$5.82M
10-K · filed 2022-03-04
2020-09-30$1.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$2.12M
derived: sum of 2 quarters · filed 2021-11-05
$3.32M
10-Q · filed 2021-11-05
$7.27M
derived: sum of 4 quarters · filed 2022-03-04
2020-06-30$790.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$1.99M
10-Q · filed 2021-08-06
$5.94M
derived: sum of 3 quarters · filed 2022-03-04
$9.07M
derived: sum of 4 quarters · filed 2022-03-04
2020-03-31$1.20M
10-Q · filed 2021-05-07
$5.15M
derived: sum of 2 quarters · filed 2022-03-04
$8.28M
derived: sum of 3 quarters · filed 2022-03-04
$10.76M
derived: sum of 4 quarters · filed 2022-03-04
2019-12-31$3.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$7.09M
derived: sum of 2 quarters · filed 2022-03-04
$9.57M
derived: sum of 3 quarters · filed 2022-03-04
$10.23M
10-K · filed 2022-03-04
2019-09-30$3.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$5.62M
derived: sum of 2 quarters · filed 2020-11-06
$6.28M
10-Q · filed 2020-11-06
$9.83M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$2.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$3.15M
10-Q · filed 2020-08-06
$6.69M
derived: sum of 3 quarters · filed 2021-03-05
$7.42M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$665.20K
10-Q · filed 2020-05-07
$4.21M
derived: sum of 2 quarters · filed 2021-03-05
$4.94M
derived: sum of 3 quarters · filed 2021-03-05
$6.46M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$3.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$4.27M
derived: sum of 2 quarters · filed 2021-03-05
$5.79M
derived: sum of 3 quarters · filed 2021-03-05
$7.38M
10-K · filed 2021-03-05
2018-09-30$727.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$2.25M
derived: sum of 2 quarters · filed 2019-11-07
$3.83M
10-Q · filed 2019-11-07
$5.23M
derived: sum of 4 quarters · filed 2020-03-06
2018-06-30$1.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$3.11M
10-Q · filed 2019-08-07
$4.51M
derived: sum of 3 quarters · filed 2020-03-06
$6.41M
derived: sum of 4 quarters · filed 2020-03-06
2018-03-31$1.58M
10-Q · filed 2019-05-08
$2.99M
derived: sum of 2 quarters · filed 2020-03-06
$4.89M
derived: sum of 3 quarters · filed 2020-03-06
$5.18M
derived: sum of 4 quarters · filed 2020-03-06
2017-12-31$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$3.31M
derived: sum of 2 quarters · filed 2020-03-06
$3.60M
derived: sum of 3 quarters · filed 2020-03-06
$3.42M
10-K · filed 2020-03-06
2017-09-30$1.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$2.20M
derived: sum of 2 quarters · filed 2018-11-07
$2.01M
10-Q · filed 2018-11-07
$4.24M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$291.53K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$106.89K
10-Q · filed 2018-08-08
$2.33M
derived: sum of 3 quarters · filed 2019-03-07
$5.75M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31-$184.65K
10-Q · filed 2018-05-08
$2.04M
derived: sum of 2 quarters · filed 2019-03-07
$5.46M
derived: sum of 3 quarters · filed 2019-03-07
2016-12-31$2.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$5.64M
derived: sum of 2 quarters · filed 2019-03-07
$9.41M
10-K · filed 2019-03-07
2016-09-30$3.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
$7.18M
10-Q · filed 2017-11-06
2016-06-30$3.76M
10-Q · filed 2017-08-04
2015-12-31$7.65M
10-K · filed 2018-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02